1. Home
  2. NEON vs AYTU Comparison

NEON vs AYTU Comparison

Compare NEON & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.65

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

N/A

Current Price

$2.66

Market Cap

25.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEON
AYTU
Founded
1997
N/A
Country
Sweden
United States
Employees
43
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
25.7M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
NEON
AYTU
Price
$1.65
$2.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$9.33
AVG Volume (30 Days)
96.7K
38.8K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
$43.34
$44.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
277.47
52 Week Low
$1.50
$0.95
52 Week High
$29.90
$3.07

Technical Indicators

Market Signals
Indicator
NEON
AYTU
Relative Strength Index (RSI) 44.20 58.29
Support Level N/A $2.14
Resistance Level $2.04 $2.72
Average True Range (ATR) 0.09 0.13
MACD -0.00 0.02
Stochastic Oscillator 34.44 83.78

Price Performance

Historical Comparison
NEON
AYTU

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: